Shield Therapeutics Employee Directory

Shield Therapeutics corporate office is located in Sihleggstrasse 23, Wollerau, Schwyz, 8832, Switzerland and has 51-200 employees.

Employees by Department

Departments

Number of employees

Sales

14

Engineering & Technical

1

Operations

1

Finance

1

Key Employees of Shield Therapeutics

  • BK
    Switzerland flag for contact location.
    Bryon Kallert

    Senior Director, Financial Planning & Analysis

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Shield Therapeutics Global Presence

globalPresence illustration
North America11-50
Europe1-10

Index of contact profiles from Shield Therapeutics

Hundreds of professionals searching for Shield Therapeutics have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Shield Therapeutics

Explore people who held key positions, contributed to Shield Therapeutics's success, and advanced their careers.

People from Similar Companies in the Manufacturing Industry Located in Switzerland

Frequently Asked Questions Regarding Shield Therapeutics Employees

How many employees does Shield Therapeutics have?
Shield Therapeutics has 51-200 employees
Who are Shield Therapeutics key employees?
Some of Shield Therapeutics key employees are Bryon Kallert
Where is Shield Therapeutics located?
Shield Therapeutics’s headquarters are located at Sihleggstrasse 23, Wollerau, Schwyz, 8832, Switzerland
How do I contact Shield Therapeutics?
Shield Therapeutics Contact Info: Phone number: +41 435080781 Website: www.shieldtherapeutics.com
What does Shield Therapeutics do?

Shield is a de-risked, commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients' unmet medical needs. The Company's clear purpose is to help its patients become people again, by enabling them to enjoy the things that make the difference in their everyday lives. The Group has a marketed product, Fe... raccru®, for the treatment of iron deficiency in adults which has exclusive IP rights until the mid-2030s. Feraccru® is commercialised in the European Union by Norgine BV and the US Food and Drug Administration (FDA) is currently considering a New Drug Application (NDA), with a PDUFA (Prescription Drug User Fee Act) date of 27th July 2019.Read More

Is Shield Therapeutics a public company?
Yes, Shield Therapeutics is a public company and is traded under the symbol STX.L
See more information about Shield Therapeutics Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.